Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Non-Current Assets: 2019-2024

Historic Non-Current Assets for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $536,000.

  • Benitec Biopharma's Non-Current Assets rose 89.42% to $1.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.2 million, marking a year-over-year increase of 89.42%. This contributed to the annual value of $536,000 for FY2024, which is 27.07% down from last year.
  • According to the latest figures from FY2024, Benitec Biopharma's Non-Current Assets is $536,000, which was down 27.07% from $735,000 recorded in FY2023.
  • In the past 5 years, Benitec Biopharma's Non-Current Assets registered a high of $1.2 million during FY2022, and its lowest value of $536,000 during FY2024.
  • Moreover, its 3-year median value for Non-Current Assets was $735,000 (2023), whereas its average is $808,000.
  • As far as peak fluctuations go, Benitec Biopharma's Non-Current Assets soared by 62.42% in 2020, and later slumped by 36.25% in 2023.
  • Benitec Biopharma's Non-Current Assets (Yearly) stood at $778,000 in 2020, then fell by 0.90% to $771,000 in 2021, then skyrocketed by 49.55% to $1.2 million in 2022, then tumbled by 36.25% to $735,000 in 2023, then dropped by 27.07% to $536,000 in 2024.